Noninvasive Molecular Markers in Gynecologic Cancers

Early detection is critical for any cancer, and molecular markers in combination with conventional diagnostic and screening methods are emerging as next-generation early diagnostic and prognostic strategies. Noninvasive Molecular Markers in Gynecologic Cancers provides a comprehensive overview of gynecologic cancer, including prevention strategies, clinical features, and biomarkers. It also covers breast cancer and fallopian tube cancer, making it a complete resource. DNA, methylation, SNPs, miRNA, mRNA, protein, autoantibodies, metabolite, and omics-based markers from remote media are emerging as noninvasive molecular markers with high specificity and sensitivity towards many cancers.

Format: Paperback / softback
Length: 516 pages
Publication date: 01 January 2021
Publisher: Taylor & Francis Ltd

Early detection is paramount in the fight against cancer, and the latest omics technologies have ushered in a new era of early diagnostic and prognostic strategies. Molecular markers, in combination with conventional diagnostic and screening methods, are emerging as powerful tools for identifying cancer at an early stage, leading to more effective treatment and improved patient care. One valuable resource for understanding noninvasive molecular diagnostic biomarkers in gynecologic cancers is the book "Noninvasive Molecular Markers in Gynecologic Cancers." Authored by leading international experts, this comprehensive guide provides a detailed overview of gynecologic cancer, including its epidemiology, clinical features, conventional diagnosis, treatment, and prognosis.

Recognizing the unique characteristics of each gynecologic cancer, the book divides its content into separate chapters covering general information, epidemiology, clinical features, and biomarkers. It also includes chapters on breast cancer and, although rare, fallopian tube cancer, to ensure a comprehensive resource.

One of the key advantages of non-invasive diagnosis is the avoidance of complications associated with biopsy and other invasive procedures. DNA, methylation, SNPs, miRNA, mRNA, protein, autoantibodies, metabolites, and omics-based markers derived from various sources, such as blood, plasma, and urine, are emerging as noninvasive molecular markers with high specificity and sensitivity toward many cancers. This book classifies these markers based on their principal characteristics and relative methods, making it a valuable resource for researchers, clinicians, and patients alike.

In conclusion, early detection is critical for improving cancer outcomes, and the latest omics technologies have opened up new avenues for identifying and treating cancer at an early stage. The book "Noninvasive Molecular Markers in Gynecologic Cancers" is a valuable resource that provides comprehensive coverage of gynecologic cancer, including its diagnosis, treatment, and prognosis. By leveraging noninvasive molecular markers and other advanced diagnostic techniques, we can hope to make significant strides in the fight against this devastating disease.

Dimension: 254 x 178 (mm)
ISBN-13: 9781138749504